These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22751586)

  • 1. Metabolic syndrome in patients with psoriatic disease.
    Gelfand JM; Yeung H
    J Rheumatol Suppl; 2012 Jul; 89():24-8. PubMed ID: 22751586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and metabolic syndrome.
    Sales R; Torres T
    Acta Dermatovenerol Croat; 2014; 22(3):169-74. PubMed ID: 25230056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.
    Pannu S; Rosmarin D
    Am J Clin Dermatol; 2021 May; 22(3):293-300. PubMed ID: 33586126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study.
    Choudhary S; Pradhan D; Pandey A; Khan MK; Lall R; Ramesh V; Puri P; Jain AK; Thomas G
    Endocr Metab Immune Disord Drug Targets; 2020; 20(5):703-717. PubMed ID: 31595859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea.
    Dalamaga M; Papadavid E; Vlami K
    Sleep Breath; 2013 May; 17(2):449-50. PubMed ID: 22821224
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis as a Predictor of Cardiometabolic Comorbidity in Women: A Study Based on the Danish National Birth Cohort.
    Blegvad C; Nybo Andersen AM; Adam A; Zachariae C; Skov L
    Acta Derm Venereol; 2019 Mar; 99(3):274-278. PubMed ID: 30460370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double trouble: psoriasis and cardiometabolic disorders.
    Mahyoodeen NG; Crowther NJ; Tikly M
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):189-194. PubMed ID: 29293257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.
    Bonanad C; González-Parra E; Rivera R; Carrascosa JM; Daudén E; Olveira A; Botella-Estrada R
    Actas Dermosifiliogr; 2017 Nov; 108(9):800-808. PubMed ID: 28610662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Co-morbidities in psoriasis vulgaris].
    Boehncke WH; Buerger C; Boehncke S
    Hautarzt; 2009 Feb; 60(2):116-21. PubMed ID: 19151962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis: classical and emerging comorbidities.
    Oliveira Mde F; Rocha Bde O; Duarte GV
    An Bras Dermatol; 2015; 90(1):9-20. PubMed ID: 25672294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
    Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
    BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in Montenegrin patients with psoriasis.
    Ražnatović-Đurović M; Janković J; Janković S
    Vojnosanit Pregl; 2016 Nov; 73(11):1016-21. PubMed ID: 29328640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.
    Al Mutairi N; Alrqobah D; Haji Hussain N
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29334162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Risk Factors and Carotid Intima-Media Thickness in a Colombian Population With Psoriasis.
    Argote A; Mora-Hernández O; Milena Aponte L; Barrera-Chaparro DI; Muñoz-Ruiz LM; Giraldo-Mordecay L; Camargo D
    Actas Dermosifiliogr; 2017 Oct; 108(8):738-745. PubMed ID: 28662815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing cardiometabolic risk profile in patients with psoriasis.
    Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
    Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Visceral Fat and Adipokines with Cardiometabolic Diseases in Psoriasis.
    Goolam Mahyoodeen N; Crowther NJ; Pillay L; Snyman T; Toman M; Daya S; Tikly M
    Acta Derm Venereol; 2019 Dec; 99(13):1218-1223. PubMed ID: 31580467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.